These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29349572)

  • 1. A prospective study evaluating indirect MRI-signs for the prediction of extraprostatic disease in patients with prostate cancer: tumor volume, tumor contact length and tumor apparent diffusion coefficient.
    Rud E; Diep L; Baco E
    World J Urol; 2018 Apr; 36(4):629-637. PubMed ID: 29349572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of extraprostatic extension by MRI tumor contact length: difference between anterior and posterior prostate cancer.
    Matsumoto K; Akita H; Narita K; Hashiguchi A; Takamatsu K; Takeda T; Kosaka T; Mizuno R; Kikuchi E; Oya M; Jinzaki M
    Prostate Cancer Prostatic Dis; 2019 Dec; 22(4):539-545. PubMed ID: 30814680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining the Tumor Contact Length and Apparent Diffusion Coefficient Better Predicts Extraprostatic Extension of Prostate Cancer with Capsular Abutment: A 3 Tesla MR Imaging Study.
    Ito K; Chiba E; Oyama-Manabe N; Washino S; Manabe O; Miyagawa T; Hamamoto K; Hiruta M; Tanno K; Shinmoto H
    Magn Reson Med Sci; 2022 Jul; 21(3):477-484. PubMed ID: 33994494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can Extraprostatic Extension Be Predicted by Tumor-Capsule Contact Length in Prostate Cancer? Relationship With International Society of Urological Pathology Grade Groups.
    Bakir B; Onay A; Vural M; Armutlu A; Yıldız SÖ; Esen T
    AJR Am J Roentgenol; 2020 Mar; 214(3):588-596. PubMed ID: 31670596
    [No Abstract]   [Full Text] [Related]  

  • 5. Prostate Cancer: Utility of Whole-Lesion Apparent Diffusion Coefficient Metrics for Prediction of Biochemical Recurrence After Radical Prostatectomy.
    Rosenkrantz AB; Ream JM; Nolan P; Rusinek H; Deng FM; Taneja SS
    AJR Am J Roentgenol; 2015 Dec; 205(6):1208-14. PubMed ID: 26587927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the most optimal multiparametric magnetic resonance imaging sequence for determining pathological length of capsular contact.
    Onay A; Vural M; Armutlu A; Ozel Yıldız S; Kiremit MC; Esen T; Bakır B
    Eur J Radiol; 2019 Mar; 112():192-199. PubMed ID: 30777210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer.
    Somford DM; Hamoen EH; Fütterer JJ; van Basten JP; Hulsbergen-van de Kaa CA; Vreuls W; van Oort IM; Vergunst H; Kiemeney LA; Barentsz JO; Witjes JA
    J Urol; 2013 Nov; 190(5):1728-34. PubMed ID: 23680307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apparent Diffusion Coefficient Values of the Benign Central Zone of the Prostate: Comparison With Low- and High-Grade Prostate Cancer.
    Gupta RT; Kauffman CR; Garcia-Reyes K; Palmeri ML; Madden JF; Polascik TJ; Rosenkrantz AB
    AJR Am J Roentgenol; 2015 Aug; 205(2):331-6. PubMed ID: 26204283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer: utility of diffusion-weighted imaging as a marker of side-specific risk of extracapsular extension.
    Rosenkrantz AB; Chandarana H; Gilet A; Deng FM; Babb JS; Melamed J; Taneja SS
    J Magn Reson Imaging; 2013 Aug; 38(2):312-9. PubMed ID: 23238968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of extraprostatic cancer by prostate specific antigen density, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer.
    Horiguchi A; Nakashima J; Horiguchi Y; Nakagawa K; Oya M; Ohigashi T; Marumo K; Murai M
    Prostate; 2003 Jun; 56(1):23-9. PubMed ID: 12746843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Index lesion characterization by (11)C-Choline PET/CT and Apparent Diffusion Coefficient parameters at 3 Tesla MRI in primary prostate carcinoma.
    Hernández-Argüello M; Quiceno H; Pascual I; Solorzano JL; Benito A; Collantes M; Rodríguez-Fraile M; Pardo J; Richter JA
    Prostate; 2016 Jan; 76(1):3-12. PubMed ID: 26390847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative Evaluation of Prostate Cancer Aggressiveness: Using ADC and ADC Ratio in Determining Gleason Score.
    Woo S; Kim SY; Cho JY; Kim SH
    AJR Am J Roentgenol; 2016 Jul; 207(1):114-20. PubMed ID: 27077643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy.
    Verma S; Rajesh A; Morales H; Lemen L; Bills G; Delworth M; Gaitonde K; Ying J; Samartunga R; Lamba M
    AJR Am J Roentgenol; 2011 Feb; 196(2):374-81. PubMed ID: 21257890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of MRI for diagnosis of extraprostatic extension in prostate cancer.
    Krishna S; Lim CS; McInnes MDF; Flood TA; Shabana WM; Lim RS; Schieda N
    J Magn Reson Imaging; 2018 Jan; 47(1):176-185. PubMed ID: 28387981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer staging: correlation between ultrasound determined tumor contact length and pathologically confirmed extraprostatic extension.
    Ukimura O; Troncoso P; Ramirez EI; Babaian RJ
    J Urol; 1998 Apr; 159(4):1251-9. PubMed ID: 9507847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiparametric magnetic resonance imaging for the assessment of extracapsular invasion and other staging parameters in patients with prostate cancer candidates for radical prostatectomy.
    Lista F; Gimbernat H; Cáceres F; Rodríguez-Barbero JM; Castillo E; Angulo JC
    Actas Urol Esp; 2014 Jun; 38(5):290-7. PubMed ID: 24387827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor contact with prostate capsule on magnetic resonance imaging: A potential biomarker for staging and prognosis.
    Kongnyuy M; Sidana A; George AK; Muthigi A; Iyer A; Ho R; Chelluri R; Mertan F; Frye TP; Su D; Merino MJ; Choyke PL; Wood BJ; Pinto PA; Turkbey B
    Urol Oncol; 2017 Jan; 35(1):30.e1-30.e8. PubMed ID: 27567248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-Tumor Quantitative Apparent Diffusion Coefficient Histogram and Texture Analysis to Predict Gleason Score Upgrading in Intermediate-Risk 3 + 4 = 7 Prostate Cancer.
    Rozenberg R; Thornhill RE; Flood TA; Hakim SW; Lim C; Schieda N
    AJR Am J Roentgenol; 2016 Apr; 206(4):775-82. PubMed ID: 27003049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Length of capsular contact for diagnosing extraprostatic extension on prostate MRI: Assessment at an optimal threshold.
    Rosenkrantz AB; Shanbhogue AK; Wang A; Kong MX; Babb JS; Taneja SS
    J Magn Reson Imaging; 2016 Apr; 43(4):990-7. PubMed ID: 26395278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer polar localization on core biopsy predicts pathologic stage.
    Hensley PJ; Bailey LR; Purdom MS; Davenport DL; Strup SE
    Can J Urol; 2016 Dec; 23(6):8551-8556. PubMed ID: 27995850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.